PYOTT DAVID E I bought TARS
February 18, 2026 · Form 4 insider transaction
PYOTT DAVID E I bought 5,893 shares of Tarsus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,893
Price
$0.00
Total value
N/A
InsiderPYOTT DAVID E I
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after5,893
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shares will vest in three equal annual installments on February 18th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service.